These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 10847128)

  • 1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.
    J Viral Hepat; 1999 Jan; 6(1):35-47. PubMed ID: 10847128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C.
    Lavanchy D; Gavinio P
    Can J Gastroenterol; 2000; 14 Suppl B():67B-76B. PubMed ID: 10938509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C: public health strategies.
    Lavanchy D
    J Hepatol; 1999; 31 Suppl 1():146-51. PubMed ID: 10622578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
    Ward JW; Hinman AR
    Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global burden of hepatitis C.
    Lavanchy D
    Liver Int; 2009 Jan; 29 Suppl 1():74-81. PubMed ID: 19207969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO.
    Artenie A; Luhmann N; Lim AG; Fraser H; Ward Z; Stone J; MacGregor L; Walker JG; Trickey A; Marquez LK; Abu-Raddad LJ; Ayoub HH; Walsh N; Hickman M; Martin NK; Easterbrook P; Vickerman P
    Lancet Gastroenterol Hepatol; 2022 Apr; 7(4):353-366. PubMed ID: 35122713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C worldwide and in Brazil: silent epidemic--data on disease including incidence, transmission, prevention, and treatment.
    Kretzer IF; do Livramento A; da Cunha J; Gonçalves S; Tosin I; Spada C; Treitinger A
    ScientificWorldJournal; 2014; 2014():827849. PubMed ID: 25013871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden of hepatitis C: considerations for healthcare providers in the United States.
    Averhoff FM; Glass N; Holtzman D
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S10-5. PubMed ID: 22715208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving epidemiology of hepatitis C virus.
    Lavanchy D
    Clin Microbiol Infect; 2011 Feb; 17(2):107-15. PubMed ID: 21091831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection: an overview of Wisconsin's public health resources.
    Hurie M; Reiser WJ; Vergeront J
    WMJ; 2006 Jan; 105(1):30-3. PubMed ID: 16676488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
    Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J;
    Liver Int; 2019 Jan; 39(1):20-30. PubMed ID: 30157316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
    Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global epidemiology and burden of hepatitis C.
    Ray Kim W
    Microbes Infect; 2002 Oct; 4(12):1219-25. PubMed ID: 12467763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A framework for management of hepatitis C in prisons.
    Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
    Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring hepatitis C virus elimination as a public health threat: Beyond global targets.
    van Santen DK; Sacks-Davis R; Doyle JS; Scott N; Prins M; Hellard M
    J Viral Hepat; 2020 Aug; 27(8):770-773. PubMed ID: 32187431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis C infection and its public health implications in Puerto Rico.
    Pérez CM; Suárez E; Torres EA
    P R Health Sci J; 2004 Jun; 23(2 Suppl):11-28. PubMed ID: 16929583
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.